{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":21,"n_cols":5,"rows_kept":21,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[9,2,9,3],[10,2,10,3],[14,2,14,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910452202503321"]
[null,null,"Titolo",null,"Immunosuppression [[electronic resource] ] : new research / / Charles B. Taylor, editor"]
[null,null,"Pubbl/distr/stampa",null,"New York, : Nova Science Pub. Inc., 2009"]
[null,null,"ISBN",null,"1-60876-707-8"]
[null,null,"Descrizione fisica",null,"1 online resource (320 p.)"]
[null,null,"Disciplina",null,"615.37"]
[null,null,"Soggetti",null,"Immunosuppression"]
[{"$nulls":4},"Immunosuppressive agents"]
[{"$nulls":4},"Electronic books."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"\"\"Immunosuppression: New Research\"\"; \"\"Contents\"\"; \"\"Preface\"\"; \"\"Is There a Future for Costimulation Blockade as a Regulatory T-cell Inducing Therapy?\"\"; \"\"Abstract\"\"; \"\"Introduction\"\"; \"\"Costimulation Blockade\"\"; \"\"Regulatory T-Cells\"\"; \"\"Conclusion\"\"; \"\"References\"\"; \"\"Strategies for T Cell Depletion to Prevent Graft versus Host Disease\"\"; \"\"Abstract\"\"; \"\"Introduction\"\"; \"\"Pharmacological Intervention\"\"; \"\"T Cell Depletion - An Effective Non-PharmacologicImmunosuppression\"\"; \"\"Pre â€?Clinical Models and Early Clinical Studies\"\"; \"\"Strategies of T Cell Depletion\"\""]
[{"$nulls":4},"\"\"Merits and Problems with TCD\"\"\"\"Haploidentical Transplantation\"\"; \"\"Strategies to Improve Outcome of Patients with TCell Depletion\"\"; \"\"Conclusions\"\"; \"\"References\"\"; \"\"Leucocyte Intracellular Cytokines in Lung Transplant Patients- A More Physiological Indicator of Immunosuppression than Plasma Drug Levels\"\"; \"\"Abstract\"\"; \"\"Introduction\"\"; \"\"Acute and Chronic Transplant Rejection\"\"; \"\"Immunosuppression\"\"; \"\"Conclusion\"\"; \"\"References\"\"; \"\"Indications and Management of m-TOR Inhibitors after Liver Transplantation\"\"; \"\"Abstract\"\"; \"\"Introduction\"\"; \"\"Objectives\"\"; \"\"Material and Methods\"\""]
[{"$nulls":4},"\"\"Results\"\"\"\"Discussion\"\"; \"\"References\"\"; \"\"Evolution of Immunosuppression in Liver Transplantation\"\"; \"\"Abstract\"\"; \"\"Abbreviations\"\"; \"\"Introduction\"\"; \"\"Evolution of Immunosuppression\"\"; \"\"Recent Advances in ImmunosuppressionFollowing Liver Transplantation\"\"; \"\"Conclusion\"\"; \"\"References\"\"; \"\"The Role of Pharmacogenomics in Tailoring Immunosuppressive Therapy for Liver Transplant Recipients\"\"; \"\"Abstract\"\"; \"\"Introduction\"\"; \"\"Current "]
[{"$nulls":4},"Immunosuppressive Drugs\"\"; \"\"Pharmacogenomics and Drug Metabolism\"\"; \"\"Genetic Polymorphism and Immunosuppressive Drugs\"\""]
[{"$nulls":4},"\"\"Limitations of Clinical application of Pharmacogenomics\"\"\"\"Conclusion\"\"; \"\"References\"\"; \"\"Immunosuppression Caused by Photochemo- and Photodynamic Therapy: Focus on Photosensitizer Photoproducts\"\"; \"\"Abstract\"\"; \"\"Introduction\"\"; \"\"Suppression of Delayed Type Hypersensitivity (DTH) Reaction by Products of Photosensitizer Photooxidation\"\"; \"\"Suppression of Contact Hypersensitivity (CHS) by PUVA-Treatment and by Photosensitizer Photoproducts\"\"; \"\"POP Therapy Is a New Patient-Friendly Photochemotherapy That Requires No UV-A Irradiation of Skin or Blood\"\"; \"\"Conclusion\"\"; \"\"References\"\""]
[{"$nulls":4},"\"\"Sunlight Induced Immunosuppression: A Role for Inflammatory Mediators in the Induction of Suppressor Cells\"\"\"\"Abstract\"\"; \"\"Introduction\"\"; \"\"Immunosuppression Only Requires Exposure toLow Doses of UV Radiation\"\"; \"\"Sunlight Is Immunosuppressive\"\"; \"\"UV-Induced Regulatory Cells\"\"; \"\"Factors Involved in the Activationof UV-Regulatory Cells\"\"; \"\"Dendritic Cells as Mediators of Regulatory T Cell Activation\"\"; \"\"Mast Cells and the Activation of RegulatoryPopulations in Secondary Lymphoid Tissues\"\"; \"\"Regulatory B Cells as Facilitatorsof UV-Immunosuppression\"\"; \"\"Conclusion\"\"; \"\"References\"\""]
[{"$nulls":4},"\"\"Immunosuppressive Therapy in Adult to Adult Living-Related Liver Transplantation\"\""]